InsiderTrades

Form 4 for SNPS Synopsys

Accepted 2021-12-16 00:00:00 ET · period of report 2021-12-15 · accession 0001199719-21-000123 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2021-12-16 2021-12-15 SNPS RUNKEL JOHN F JR GC, Corp. Sec S - Sale+OE $350.00 -6,516 22.9K -22% -$2.28M
DM 2021-12-16 2021-12-15 SNPS RUNKEL JOHN F JR GC, Corp. Sec M - OptEx $151.53 +6,516 24.4K +36% +$987.4K
D 2021-12-16 2021-12-15 SNPS RUNKEL JOHN F JR GC, Corp. Sec G - Gift $0.00 -300 22.9K -1% $0
DM 2021-12-16 2021-12-15 SNPS RUNKEL JOHN F JR GC, Corp. Sec M - OptEx $0.00 -6,516 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-12-15 S D 1,323 $350.00 22,866 D — —
2 Common Common Stock 2021-12-15 M A 2,278 $234.17 25,144 D — —
3 Common Common Stock 2021-12-15 S D 2,278 $350.00 22,866 D — —
4 Common Common Stock 2021-12-15 S D 1,572 $350.00 22,866 D — —
5 Common Common Stock 2021-12-15 M A 1,343 $90.51 24,209 D — —
6 Common Common Stock 2021-12-15 S D 1,343 $350.00 22,866 D — —
7 Common Common Stock 2021-12-15 M A 1,323 $89.76 24,189 D — —
8 Common Common Stock 2021-12-15 G D 300 $0.00 22,866 D — — (F1) Gift
9 Common Common Stock 2021-12-15 M A 1,572 $135.88 24,438 D — —
10 Derivative Non-Qualified Stock Option (right to buy) 2021-12-15 M D 2,278 $0.00 6,833 D $234.17 · 2021-12-10 to 2027-12-10 2,278 Common Stock (F2) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
11 Derivative Non-Qualified Stock Option (right to buy) 2021-12-15 M D 1,323 $0.00 5,291 D $89.76 · 2019-12-12 to 2025-12-12 1,323 Common Stock (F2) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
12 Derivative Non-Qualified Stock Option (right to buy) 2021-12-15 M D 1,572 $0.00 12,576 D $135.88 · 2020-12-12 to 2026-12-12 1,572 Common Stock (F2) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
13 Derivative Non-Qualified Stock Option (right to buy) 2021-12-15 M D 1,343 $0.00 0 D $90.51 · 2018-12-08 to 2024-12-08 1,343 Common Stock